■评估西班牙队列中使用不同的单片丙烯酸单焦点人工晶体进行白内障手术后长达五年的掺钕钇铝石榴石激光(Nd:YAG)囊切开术的发生率。
■数据是从电子病历中提取的。符合条件的参与者年龄≥65岁,使用五种不同的丙烯酸单焦点IOL(AlconAcrySof,AJLLLASY60,MediconturBi-flex,IOLTechStabibag和ZeissAsphina),和超过六个月的基线数据。参与者从手术后随访5年,从Nd:YAG随访6个月。在IOL之间比较Nd:YAG的发生率,并进行多变量分析以确定白内障手术后五年Nd:YAG发生率的预测因素。
■最初的队列包括9545名患者,14,519只眼(53%为女性,平均年龄75岁)。其中,白内障手术五年后,有3955只眼可用于分析。在手术后的五年里,AlconAcrysofIOL的Nd:YAG发病率始终低于其他IOL。五年时,AlconAcrysof的Nd:YAG发病率为8.8%。相比之下,AJLLLASY60的发生率为47.4%(OR=9.54,95%CI[6.57,13.84]),蔡司Asphina为44.3%(OR=8.35,95%CI[5.85,11.94]),IOLTechStabibag为44.0%(OR=8.02,95%CI[4.60,13.84])。
AlconAcrySofIOL在白内障手术后的长期随访期内,Nd:YAG发病率始终较低,强调IOL选择对患者长期预后的重要性。
UNASSIGNED: To estimate the incidence of neodymium-doped yttrium aluminum garnet laser (
Nd:YAG) capsulotomy up to five years after cataract surgery with different single-piece acrylic monofocal IOLs in a Spanish cohort.
UNASSIGNED: Data were extracted from electronic medical records. Eligible participants were aged ≥65, had cataract surgery with one of five different acrylic monofocal IOLs (Alcon AcrySof, AJL LLASY60, Medicontur Bi-flex, IOL Tech Stabibag and Zeiss Asphina), and more than six months baseline data. Participants were followed up to five years from surgery and up to six months from
Nd:YAG. The incidence of Nd:YAG was compared between the IOLs and multivariate analyses were conducted to identify predictors of
Nd:YAG incidence at five-years after cataract surgery.
UNASSIGNED: The initial cohort included 9545 patients with 14,519 eyes (53% female, average age 75 years). Of those, 3955 eyes were available for analysis five years after cataract surgery. Throughout the five years post-surgery,
Nd:YAG incidence was consistently lower with Alcon Acrysof IOLs than the other IOLs. At five years the
Nd:YAG incidence rate for Alcon Acrysof was 8.8%. In comparison, the incidence was 47.4% for AJL LLASY60 (OR = 9.54, 95% CI [6.57, 13.84]), 44.3% for Zeiss Asphina (OR = 8.35, 95% CI [5.85, 11.94]) and 44.0% for IOL Tech Stabibag (OR = 8.02, 95% CI [4.60, 13.84]).
UNASSIGNED: Alcon AcrySof IOLs have a consistently lower risk of Nd:YAG incidence over a long follow-up period after cataract surgery, highlighting the importance of IOL choice for patients\' long-term outcomes.